JP2021501806A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021501806A5 JP2021501806A5 JP2020544335A JP2020544335A JP2021501806A5 JP 2021501806 A5 JP2021501806 A5 JP 2021501806A5 JP 2020544335 A JP2020544335 A JP 2020544335A JP 2020544335 A JP2020544335 A JP 2020544335A JP 2021501806 A5 JP2021501806 A5 JP 2021501806A5
- Authority
- JP
- Japan
- Prior art keywords
- azaspiro
- cyclopropyl
- isoxazole
- carboxylic acid
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 cyano, hydroxyl Chemical group 0.000 claims 95
- 239000002253 acid Substances 0.000 claims 19
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000000623 heterocyclic group Chemical group 0.000 claims 15
- 125000002947 alkylene group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 13
- 229910052760 oxygen Inorganic materials 0.000 claims 13
- 239000012453 solvate Substances 0.000 claims 12
- 229910052717 sulfur Inorganic materials 0.000 claims 12
- 125000003118 aryl group Chemical group 0.000 claims 11
- 125000003545 alkoxy group Chemical group 0.000 claims 10
- 125000004452 carbocyclyl group Chemical group 0.000 claims 10
- 125000005843 halogen group Chemical group 0.000 claims 10
- 125000005842 heteroatom Chemical group 0.000 claims 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 9
- 125000001188 haloalkyl group Chemical group 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 8
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 claims 8
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 7
- 125000004103 aminoalkyl group Chemical group 0.000 claims 7
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims 7
- 125000004438 haloalkoxy group Chemical group 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- HSWCABTYQVCNCT-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F HSWCABTYQVCNCT-UHFFFAOYSA-N 0.000 claims 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 6
- 125000003282 alkyl amino group Chemical group 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- SUOMEPOKHNAXGW-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindole-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=CN(C2=C1)C)C(=O)O SUOMEPOKHNAXGW-UHFFFAOYSA-N 0.000 claims 5
- 235000001968 nicotinic acid Nutrition 0.000 claims 5
- 239000011664 nicotinic acid Substances 0.000 claims 5
- 229960003512 nicotinic acid Drugs 0.000 claims 5
- 125000004076 pyridyl group Chemical group 0.000 claims 5
- LIISZMRTGKWIFN-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-1,3-dioxa-8-azaspiro[4.5]decan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1OC2(CO1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F LIISZMRTGKWIFN-UHFFFAOYSA-N 0.000 claims 4
- WMKYKQWKLILFBM-UHFFFAOYSA-N 2h-pyridine-1-carboxylic acid Chemical compound OC(=O)N1CC=CC=C1 WMKYKQWKLILFBM-UHFFFAOYSA-N 0.000 claims 4
- FSJONNQIJMENSS-UHFFFAOYSA-N 4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]benzoic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C(C(=O)O)C=C1 FSJONNQIJMENSS-UHFFFAOYSA-N 0.000 claims 4
- SDPRBFSOTHXFGV-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindazole-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=NN(C2=C1)C)C(=O)O SDPRBFSOTHXFGV-UHFFFAOYSA-N 0.000 claims 4
- 206010016654 Fibrosis Diseases 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 4
- 230000004761 fibrosis Effects 0.000 claims 4
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 4
- 125000004474 heteroalkylene group Chemical group 0.000 claims 4
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 4
- 125000004043 oxo group Chemical group O=* 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- QFDHYWGYDUSMOX-UHFFFAOYSA-N 2-[3-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-1-oxa-8-azaspiro[4.5]dec-3-en-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C=1COC2(C=1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F QFDHYWGYDUSMOX-UHFFFAOYSA-N 0.000 claims 3
- UWAUOLUWECSAFZ-UHFFFAOYSA-N 3-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]benzoic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C(C(=O)O)C=CC=1 UWAUOLUWECSAFZ-UHFFFAOYSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 3
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 2
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 2
- GERSIKCSWYDFSJ-UHFFFAOYSA-N 1,2,4-triazine-5-carboxylic acid Chemical compound OC(=O)C1=CN=NC=N1 GERSIKCSWYDFSJ-UHFFFAOYSA-N 0.000 claims 2
- NDMFETHQFUOIQX-UHFFFAOYSA-N 1-(3-chloropropyl)imidazolidin-2-one Chemical compound ClCCCN1CCNC1=O NDMFETHQFUOIQX-UHFFFAOYSA-N 0.000 claims 2
- OPKSRSICFGPFJR-NNCDRQEWSA-N 2-[(1'R,5'S)-2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]spiro[1,3-dioxolane-4,3'-8-azabicyclo[3.2.1]octane]-8'-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1OCC2(O1)C[C@H]1CC[C@@H](C2)N1C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F OPKSRSICFGPFJR-NNCDRQEWSA-N 0.000 claims 2
- AZFSXHXCSHYXTJ-UHFFFAOYSA-N 2-[2-[2-(3,5-dichloropyridin-4-yl)-4-(difluoromethyl)pyrazol-3-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound ClC=1C=NC=C(C=1N1N=CC(=C1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C(F)F)Cl AZFSXHXCSHYXTJ-UHFFFAOYSA-N 0.000 claims 2
- UWRCWLXYNLAUAI-UHFFFAOYSA-N 2-[2-[3-(2,6-dichlorophenyl)-5-propan-2-yl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)Cl)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C(C)C UWRCWLXYNLAUAI-UHFFFAOYSA-N 0.000 claims 2
- LYVPDXCHQNZONE-UHFFFAOYSA-N 2-[2-[3-(2-chloro-6-fluorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)F)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C1CC1 LYVPDXCHQNZONE-UHFFFAOYSA-N 0.000 claims 2
- QEPOHZWOLPXQMZ-UHFFFAOYSA-N 2-[2-[3-(2-chloro-6-methylphenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)C)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C1CC1 QEPOHZWOLPXQMZ-UHFFFAOYSA-N 0.000 claims 2
- OLQSHPAFFXHZHZ-UHFFFAOYSA-N 2-[2-[3-(3,5-dichloropyridin-4-yl)-5-propan-2-yl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound ClC=1C=NC=C(C=1C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C(C)C)Cl OLQSHPAFFXHZHZ-UHFFFAOYSA-N 0.000 claims 2
- WWRFHHWIFULLSF-UHFFFAOYSA-N 2-[2-[3-(3-chloropyridin-2-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound ClC=1C(=NC=CC=1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C1CC1 WWRFHHWIFULLSF-UHFFFAOYSA-N 0.000 claims 2
- UTZCPVCTWPUNHY-UHFFFAOYSA-N 2-[2-[4-(difluoromethyl)-2-[2-(trifluoromethyl)phenyl]pyrazol-3-yl]-7-azaspiro[3.5]nonan-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound FC(C=1C=NN(C=1C1CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C1=C(C=CC=C1)C(F)(F)F)F UTZCPVCTWPUNHY-UHFFFAOYSA-N 0.000 claims 2
- ZNHPXUVBWZQRFH-UHFFFAOYSA-N 2-[2-[4-(difluoromethyl)-2-[2-(trifluoromethyl)phenyl]pyrazol-3-yl]-7-azaspiro[3.5]nonan-7-yl]-4-methyl-1,3-benzothiazole-6-carboxylic acid Chemical compound FC(C=1C=NN(C=1C1CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)C)C1=C(C=CC=C1)C(F)(F)F)F ZNHPXUVBWZQRFH-UHFFFAOYSA-N 0.000 claims 2
- MYZPXNREXDHGIQ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichloro-4-fluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=C(C=C1Cl)F)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F MYZPXNREXDHGIQ-UHFFFAOYSA-N 0.000 claims 2
- TTWBXUXKEORCTA-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-2-hydroxy-7-azaspiro[3.5]nonan-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1(CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)O TTWBXUXKEORCTA-UHFFFAOYSA-N 0.000 claims 2
- LUPWLIXDLUZHQX-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-2-hydroxyspiro[3.5]nonan-7-yl]oxy-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1(CC2(C1)CCC(CC2)OC=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)O LUPWLIXDLUZHQX-UHFFFAOYSA-N 0.000 claims 2
- ZIWDUYVXURUKBR-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C=CC(=C2)C(=O)O ZIWDUYVXURUKBR-UHFFFAOYSA-N 0.000 claims 2
- ZOUZHZUQFXBCFZ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1,3-benzoxazole-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1OC2=C(N=1)C=C(C=C2)C(=O)O ZOUZHZUQFXBCFZ-UHFFFAOYSA-N 0.000 claims 2
- SHIZQXZRYCJGMX-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1,3-benzoxazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1OC2=C(N=1)C=CC(=C2)C(=O)O SHIZQXZRYCJGMX-UHFFFAOYSA-N 0.000 claims 2
- BSLDHPKNJLYGFT-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylbenzimidazole-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC2=C(N1C)C=CC(=C2)C(=O)O BSLDHPKNJLYGFT-UHFFFAOYSA-N 0.000 claims 2
- ZYJBEGYNUPPPFA-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-6-methylpyrimidine-4-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC(=CC(=N1)C(=O)O)C ZYJBEGYNUPPPFA-UHFFFAOYSA-N 0.000 claims 2
- KDWAQUZOLNXTKG-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-7-methylpyrrolo[2,3-d]pyrimidine-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1N=CC2=C(N=1)N(C=C2C(=O)O)C KDWAQUZOLNXTKG-UHFFFAOYSA-N 0.000 claims 2
- RRGATMQOHYKZSX-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-N-cyclopropylsulfonyl-4-fluoro-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)NS(=O)(=O)C1CC1)F RRGATMQOHYKZSX-UHFFFAOYSA-N 0.000 claims 2
- GRXIUVFREHQJNT-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC=2C(=NC=C(C=2)C(=O)O)N=1 GRXIUVFREHQJNT-UHFFFAOYSA-N 0.000 claims 2
- RBBJHCYUAQPSCM-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyrimidine-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC=C(C=N1)C(=O)O RBBJHCYUAQPSCM-UHFFFAOYSA-N 0.000 claims 2
- SRVWJMQQFOTYMZ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]nonan-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F SRVWJMQQFOTYMZ-UHFFFAOYSA-N 0.000 claims 2
- KYWLJQVWQCNDKU-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]spiro[3.5]non-2-en-7-yl]oxy-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCC(CC2)OC=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F KYWLJQVWQCNDKU-UHFFFAOYSA-N 0.000 claims 2
- IQJYMTOLMAUPLN-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)triazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C=1N=NN(C=1C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F)C1=C(C=CC=C1Cl)Cl IQJYMTOLMAUPLN-UHFFFAOYSA-N 0.000 claims 2
- DWEUKVKIBLPATL-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-difluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1F)F)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F DWEUKVKIBLPATL-UHFFFAOYSA-N 0.000 claims 2
- XKMCMGOHWRBXSK-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C=CC(=C2)C(=O)O XKMCMGOHWRBXSK-UHFFFAOYSA-N 0.000 claims 2
- OKQCZNGBKUMOQU-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethoxy)-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)OC(F)(F)F OKQCZNGBKUMOQU-UHFFFAOYSA-N 0.000 claims 2
- OKGCUSLQEZKNIG-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)N)F OKGCUSLQEZKNIG-UHFFFAOYSA-N 0.000 claims 2
- AWMVITFYNBJOTG-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F AWMVITFYNBJOTG-UHFFFAOYSA-N 0.000 claims 2
- JTPWRAMENPUBLY-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-N-methyl-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)NC)F JTPWRAMENPUBLY-UHFFFAOYSA-N 0.000 claims 2
- WJZIUTAYTYKRHK-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-N-propan-2-yl-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)NC(C)C)F WJZIUTAYTYKRHK-UHFFFAOYSA-N 0.000 claims 2
- VSSRJYHXEFICFJ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-N-sulfamoyl-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)NS(N)(=O)=O)F VSSRJYHXEFICFJ-UHFFFAOYSA-N 0.000 claims 2
- RLYHIMDAXHMJPE-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxy-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)OC RLYHIMDAXHMJPE-UHFFFAOYSA-N 0.000 claims 2
- HZFPOWLMPFSUOB-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methyl-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)C HZFPOWLMPFSUOB-UHFFFAOYSA-N 0.000 claims 2
- JIBVIIUUPKEJRZ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-5-methoxy-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C=C(C(=C2)C(=O)O)OC JIBVIIUUPKEJRZ-UHFFFAOYSA-N 0.000 claims 2
- AVSAGQFUILFWFR-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-6-methoxy-1,3-benzothiazole-4-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC=2C(N=1)=C(C=C(C=2)OC)C(=O)O AVSAGQFUILFWFR-UHFFFAOYSA-N 0.000 claims 2
- JEHUKZVMXJYQAA-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-7-(trifluoromethyl)quinoline-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC=2C=C(C=C(C=2C=C1)C(=O)O)C(F)(F)F JEHUKZVMXJYQAA-UHFFFAOYSA-N 0.000 claims 2
- AXZGMIBDRYHJGG-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-8-methoxyquinoline-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC=2C(=CC=C(C=2C=C1)C(=O)O)OC AXZGMIBDRYHJGG-UHFFFAOYSA-N 0.000 claims 2
- OLUCEJHCIDASIR-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-N-cyclopropylsulfonyl-4-fluoro-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)NS(=O)(=O)C1CC1)F OLUCEJHCIDASIR-UHFFFAOYSA-N 0.000 claims 2
- UUSDSGBPWJJVMZ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-N-ethyl-4-fluoro-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)NCC)F UUSDSGBPWJJVMZ-UHFFFAOYSA-N 0.000 claims 2
- XKVTUDWQLKQMDX-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-[1,3]thiazolo[5,4-b]pyridine-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1SC2=NC(=CC=C2N=1)C(=O)O XKVTUDWQLKQMDX-UHFFFAOYSA-N 0.000 claims 2
- DLGUEYSYYUGGQZ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC=2C=CC=C(C=2C=C1)C(=O)O DLGUEYSYYUGGQZ-UHFFFAOYSA-N 0.000 claims 2
- FAYMBBNLAXCTGK-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(3,5-difluoropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1F)F)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F FAYMBBNLAXCTGK-UHFFFAOYSA-N 0.000 claims 2
- YZDUXZWPRUQLIL-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-1,3-dioxa-8-azaspiro[4.5]decan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1OC2(CO1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F YZDUXZWPRUQLIL-UHFFFAOYSA-N 0.000 claims 2
- AHBXJXIQDITTRI-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F AHBXJXIQDITTRI-UHFFFAOYSA-N 0.000 claims 2
- UISPRMNEZHHHKK-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC2=CC=C(C=C2C=C1)C(=O)O UISPRMNEZHHHKK-UHFFFAOYSA-N 0.000 claims 2
- ZRMNEGMKVZOPDP-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-6-methylpyrimidine-4-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC(=CC(=N1)C(=O)O)C ZRMNEGMKVZOPDP-UHFFFAOYSA-N 0.000 claims 2
- VZAPQGMVTYZJLN-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-[1,3]thiazolo[5,4-b]pyridine-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1SC2=NC(=CC=C2N=1)C(=O)O VZAPQGMVTYZJLN-UHFFFAOYSA-N 0.000 claims 2
- BPVDVJQTDDXUMD-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyrrolo[2,1-f][1,2,4]triazine-5-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NN2C(C=N1)=C(C=C2)C(=O)O BPVDVJQTDDXUMD-UHFFFAOYSA-N 0.000 claims 2
- HXXVVZXBTYPWJS-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoxaline-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC2=CC=C(C=C2N=C1)C(=O)O HXXVVZXBTYPWJS-UHFFFAOYSA-N 0.000 claims 2
- CYHXRQJQWYSXQQ-UHFFFAOYSA-N 2-[3'-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]spiro[8-azabicyclo[3.2.1]octane-3,1'-cyclobutane]-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1CC2(C1)CC1CCC(C2)N1C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F CYHXRQJQWYSXQQ-UHFFFAOYSA-N 0.000 claims 2
- YAQKEYXGXVYKFQ-UHFFFAOYSA-N 2-[3-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1OC2(OC1)CCN(CC2)C=1SC2=C(N=1)C(=CC(=C2)C(=O)O)F YAQKEYXGXVYKFQ-UHFFFAOYSA-N 0.000 claims 2
- BHDJUAFZNIWISJ-UHFFFAOYSA-N 2-[6-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-2-azaspiro[3.3]hept-6-en-2-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(CN(C2)C=2SC3=C(N=2)C(=CC(=C3)C(=O)O)F)C1 BHDJUAFZNIWISJ-UHFFFAOYSA-N 0.000 claims 2
- SXTJHIPACWRISC-UHFFFAOYSA-N 2-hydroxyoxane-2-carboxylic acid Chemical compound OC(=O)C1(O)CCCCO1 SXTJHIPACWRISC-UHFFFAOYSA-N 0.000 claims 2
- XQRBBNBJCFYTDX-UHFFFAOYSA-N 3-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-2-hydroxyspiro[3.5]nonan-7-yl]oxybenzoic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1(CC2(C1)CCC(CC2)OC=1C=C(C(=O)O)C=CC=1)O XQRBBNBJCFYTDX-UHFFFAOYSA-N 0.000 claims 2
- UHDSCTIGBYQNSV-UHFFFAOYSA-N 3-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NN(C2=CC(=CC=C12)C(=O)O)C UHDSCTIGBYQNSV-UHFFFAOYSA-N 0.000 claims 2
- REIQTABSJJZWOQ-UHFFFAOYSA-N 3-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylpyrazolo[4,3-b]pyridine-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NN(C=2C1=NC=C(C=2)C(=O)O)C REIQTABSJJZWOQ-UHFFFAOYSA-N 0.000 claims 2
- YAXCQRUOIDBASP-UHFFFAOYSA-N 3-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindazole-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NN(C2=CC(=CC=C12)C(=O)O)C YAXCQRUOIDBASP-UHFFFAOYSA-N 0.000 claims 2
- AKJRHNHVTAAUQL-UHFFFAOYSA-N 3-[[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-2-hydroxyspiro[3.5]nonan-7-yl]oxymethyl]benzoic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1(CC2(C1)CCC(CC2)OCC=1C=C(C(=O)O)C=CC=1)O AKJRHNHVTAAUQL-UHFFFAOYSA-N 0.000 claims 2
- AQFAKTHAOLWCDG-UHFFFAOYSA-N 4-[2-[3-(2-chlorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]benzoic acid Chemical compound ClC1=C(C=CC=C1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C(C(=O)O)C=C1)C1CC1 AQFAKTHAOLWCDG-UHFFFAOYSA-N 0.000 claims 2
- WHVKNPGPTFPWEQ-UHFFFAOYSA-N 4-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-2-hydroxyspiro[3.5]nonan-7-yl]oxybenzoic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1(CC2(C1)CCC(CC2)OC1=CC=C(C(=O)O)C=C1)O WHVKNPGPTFPWEQ-UHFFFAOYSA-N 0.000 claims 2
- DVMXXSLSGKLUKP-UHFFFAOYSA-N 5-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyridine-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=CC(=NC=1)C(=O)O DVMXXSLSGKLUKP-UHFFFAOYSA-N 0.000 claims 2
- VPJJJVTYBPWFBR-UHFFFAOYSA-N 5-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindazole-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=NN(C2=CC=1)C)C(=O)O VPJJJVTYBPWFBR-UHFFFAOYSA-N 0.000 claims 2
- BLZHNGJZBLBXEX-UHFFFAOYSA-N 5-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylpyrrolo[2,3-c]pyridine-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CN=1)N(C(=C2)C(=O)O)C BLZHNGJZBLBXEX-UHFFFAOYSA-N 0.000 claims 2
- CEMCQYVNKVSQTD-UHFFFAOYSA-N 6-[2-(3-cyclohexyl-5-cyclopropyl-1,2-oxazol-4-yl)-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindole-3-carboxylic acid Chemical compound C1(CCCCC1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C(=CN(C2=C1)C)C(=O)O)C1CC1 CEMCQYVNKVSQTD-UHFFFAOYSA-N 0.000 claims 2
- GKJRHBGSJYIOLZ-UHFFFAOYSA-N 6-[2-(3-cyclohexyl-5-cyclopropyl-1,2-oxazol-4-yl)-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound C1(CCCCC1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C1CC1 GKJRHBGSJYIOLZ-UHFFFAOYSA-N 0.000 claims 2
- MOFPIIUDBMDJSN-UHFFFAOYSA-N 6-[2-[3-(2,6-dichlorophenyl)-5-propan-2-yl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)Cl)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C(C)C MOFPIIUDBMDJSN-UHFFFAOYSA-N 0.000 claims 2
- LFYXCXFOZYAZGI-UHFFFAOYSA-N 6-[2-[3-(2-chloro-4-fluorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound ClC1=C(C=CC(=C1)F)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C1CC1 LFYXCXFOZYAZGI-UHFFFAOYSA-N 0.000 claims 2
- JNHCLLGYVWBUIT-UHFFFAOYSA-N 6-[2-[3-(2-chloro-6-fluorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)F)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C1CC1 JNHCLLGYVWBUIT-UHFFFAOYSA-N 0.000 claims 2
- UJYCBZKDVGIEPD-UHFFFAOYSA-N 6-[2-[3-(2-chloro-6-fluorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)F)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O)C1CC1 UJYCBZKDVGIEPD-UHFFFAOYSA-N 0.000 claims 2
- OCPSXWOMCOFBGV-UHFFFAOYSA-N 6-[2-[3-(2-chloro-6-methylphenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)C)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C1CC1 OCPSXWOMCOFBGV-UHFFFAOYSA-N 0.000 claims 2
- BLKIDVGDNKMSMJ-UHFFFAOYSA-N 6-[2-[3-(2-chloro-6-methylphenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)C)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O)C1CC1 BLKIDVGDNKMSMJ-UHFFFAOYSA-N 0.000 claims 2
- AFOOMDKFFNXGIW-UHFFFAOYSA-N 6-[2-[3-(3,5-dichloropyridin-4-yl)-5-propan-2-yl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound ClC=1C=NC=C(C=1C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C(C)C)Cl AFOOMDKFFNXGIW-UHFFFAOYSA-N 0.000 claims 2
- ZHLIDCKSNLBMRJ-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-2-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(difluoromethoxy)quinoline-2-carboxylic acid Chemical compound ClC=1C(=NC=CC=1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(F)F)C1CC1 ZHLIDCKSNLBMRJ-UHFFFAOYSA-N 0.000 claims 2
- KQBATTWANJDQJT-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-2-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound ClC=1C(=NC=CC=1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F)C1CC1 KQBATTWANJDQJT-UHFFFAOYSA-N 0.000 claims 2
- FJEGASLQTFTAPW-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-2-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxyquinoline-2-carboxylic acid Chemical compound ClC=1C(=NC=CC=1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC)C1CC1 FJEGASLQTFTAPW-UHFFFAOYSA-N 0.000 claims 2
- VRLNJABARCNNFT-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-2-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound ClC=1C(=NC=CC=1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O)C1CC1 VRLNJABARCNNFT-UHFFFAOYSA-N 0.000 claims 2
- CILKRDHHPWGVPC-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-4-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(difluoromethoxy)quinoline-2-carboxylic acid Chemical compound ClC=1C=NC=CC=1C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(F)F)C1CC1 CILKRDHHPWGVPC-UHFFFAOYSA-N 0.000 claims 2
- LRKCLTZXYNXEIZ-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-4-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxyquinoline-2-carboxylic acid Chemical compound ClC=1C=NC=CC=1C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC)C1CC1 LRKCLTZXYNXEIZ-UHFFFAOYSA-N 0.000 claims 2
- XGCFMWFNEYKHMZ-UHFFFAOYSA-N 6-[2-[3-(3-chloropyridin-4-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound ClC=1C=NC=CC=1C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O)C1CC1 XGCFMWFNEYKHMZ-UHFFFAOYSA-N 0.000 claims 2
- DTCQHSJFLJZNNW-UHFFFAOYSA-N 6-[2-[4-(difluoromethyl)-2-[2-(trifluoromethyl)phenyl]pyrazol-3-yl]-7-azaspiro[3.5]nonan-7-yl]-1-methylindole-3-carboxylic acid Chemical compound FC(C=1C=NN(C=1C1CC2(C1)CCN(CC2)C1=CC=C2C(=CN(C2=C1)C)C(=O)O)C1=C(C=CC=C1)C(F)(F)F)F DTCQHSJFLJZNNW-UHFFFAOYSA-N 0.000 claims 2
- AZVNKEPVQILRDX-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichloro-4-fluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=C(C=C1Cl)F)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F AZVNKEPVQILRDX-UHFFFAOYSA-N 0.000 claims 2
- VRFMOSIMQZRRPA-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichloro-4-fluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=C(C=C1Cl)F)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC VRFMOSIMQZRRPA-UHFFFAOYSA-N 0.000 claims 2
- HDWKXTMKQRXZSE-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichloro-4-fluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-propan-2-yloxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=C(C=C1Cl)F)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(C)C HDWKXTMKQRXZSE-UHFFFAOYSA-N 0.000 claims 2
- DNHONPYJPUPDJP-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichloro-4-fluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=C(C=C1Cl)F)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O DNHONPYJPUPDJP-UHFFFAOYSA-N 0.000 claims 2
- ZRSOFPIYYNLSDC-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-(2-trimethylsilylethoxymethyl)indole-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=CN(C2=C1)COCC[Si](C)(C)C)C(=O)O ZRSOFPIYYNLSDC-UHFFFAOYSA-N 0.000 claims 2
- ABEUFSGCMAZWCF-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindazole-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=NN(C2=C1)C)C(=O)O ABEUFSGCMAZWCF-UHFFFAOYSA-N 0.000 claims 2
- DDERFKUXIPUURA-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindole-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N(C2=C1)C)C(=O)O DDERFKUXIPUURA-UHFFFAOYSA-N 0.000 claims 2
- DMEXKGDWMCFTLU-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylpyrrolo[2,3-b]pyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=N1)N(C=C2C(=O)O)C DMEXKGDWMCFTLU-UHFFFAOYSA-N 0.000 claims 2
- RZXAEHFPVGAJRG-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyridine-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=CC(=N1)C(=O)O RZXAEHFPVGAJRG-UHFFFAOYSA-N 0.000 claims 2
- KWEDVRBXRXNSQB-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-difluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F KWEDVRBXRXNSQB-UHFFFAOYSA-N 0.000 claims 2
- YIMJXCNDELXBMU-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-difluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O YIMJXCNDELXBMU-UHFFFAOYSA-N 0.000 claims 2
- SMXCWZQTGSMHFQ-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(2-hydroxyethoxy)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OCCO SMXCWZQTGSMHFQ-UHFFFAOYSA-N 0.000 claims 2
- YIRPELGNXFSRBN-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(difluoromethoxy)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(F)F YIRPELGNXFSRBN-UHFFFAOYSA-N 0.000 claims 2
- WPGAVSDZYIRUGE-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F WPGAVSDZYIRUGE-UHFFFAOYSA-N 0.000 claims 2
- LAHZVBUOKWIPNU-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-ethoxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OCC LAHZVBUOKWIPNU-UHFFFAOYSA-N 0.000 claims 2
- GCLRCFQQGUPZBQ-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxypyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC=C(C(=O)O)C(=C1)OC GCLRCFQQGUPZBQ-UHFFFAOYSA-N 0.000 claims 2
- AUKUERAKBLFUKO-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC AUKUERAKBLFUKO-UHFFFAOYSA-N 0.000 claims 2
- TVAUJLNXTLXMOE-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methylquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C TVAUJLNXTLXMOE-UHFFFAOYSA-N 0.000 claims 2
- LZSXRQCQUMGJBV-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-propan-2-yloxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(C)C LZSXRQCQUMGJBV-UHFFFAOYSA-N 0.000 claims 2
- GVLBROJHBALOBD-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O GVLBROJHBALOBD-UHFFFAOYSA-N 0.000 claims 2
- HJWIWPYFOCMHJY-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(3,5-difluoropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F HJWIWPYFOCMHJY-UHFFFAOYSA-N 0.000 claims 2
- HZOVZLUVBURGHY-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-1,3-dioxa-8-azaspiro[4.5]decan-8-yl]pyridine-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1OC2(CO1)CCN(CC2)C1=CC=CC(=N1)C(=O)O HZOVZLUVBURGHY-UHFFFAOYSA-N 0.000 claims 2
- FOKYWJFRYPLJJP-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindazole-3-carbonitrile Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=NN(C2=C1)C)C#N FOKYWJFRYPLJJP-UHFFFAOYSA-N 0.000 claims 2
- NGWJWIVLKRWULX-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-3-(trifluoromethyl)imidazo[1,5-a]pyridine-1-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=CC=2N(C=1)C(=NC=2C(=O)O)C(F)(F)F NGWJWIVLKRWULX-UHFFFAOYSA-N 0.000 claims 2
- RXGBUMPSDSTQLN-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-ethoxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OCC RXGBUMPSDSTQLN-UHFFFAOYSA-N 0.000 claims 2
- ZDOHBTSUKXSISZ-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-propan-2-yloxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(C)C ZDOHBTSUKXSISZ-UHFFFAOYSA-N 0.000 claims 2
- MJLCYGLEBHWUTA-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-5-fluoropyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC=C(C(=O)O)C=C1F MJLCYGLEBHWUTA-UHFFFAOYSA-N 0.000 claims 2
- UAPNPCJVWAFKNB-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyridazine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C(N=N1)C(=O)O UAPNPCJVWAFKNB-UHFFFAOYSA-N 0.000 claims 2
- YCFOXYIBSKKZQM-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)OC(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC=C(C(=O)O)C=C1 YCFOXYIBSKKZQM-UHFFFAOYSA-N 0.000 claims 2
- XZYGXULQBKRWJR-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-1-methylindole-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C(=CN(C2=C1)C)C(=O)O XZYGXULQBKRWJR-UHFFFAOYSA-N 0.000 claims 2
- GXLJPSVMLCCDAC-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(2-hydroxyethoxy)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OCCO GXLJPSVMLCCDAC-UHFFFAOYSA-N 0.000 claims 2
- SLFHKAYGYSSRIL-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(difluoromethoxy)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(F)F SLFHKAYGYSSRIL-UHFFFAOYSA-N 0.000 claims 2
- QLJTXDLVICXBJC-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)pyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC=C(C(=O)O)C(=C1)C(F)(F)F QLJTXDLVICXBJC-UHFFFAOYSA-N 0.000 claims 2
- BQHPKGXDMXWAFX-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)C(F)(F)F BQHPKGXDMXWAFX-UHFFFAOYSA-N 0.000 claims 2
- LAAAIMKHZIWJNX-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-ethoxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OCC LAAAIMKHZIWJNX-UHFFFAOYSA-N 0.000 claims 2
- ZDZISTYHQOHAQA-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC ZDZISTYHQOHAQA-UHFFFAOYSA-N 0.000 claims 2
- CZTHZXZBAROPOC-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-propan-2-yloxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC(C)C CZTHZXZBAROPOC-UHFFFAOYSA-N 0.000 claims 2
- KDHDWEZUYPKULD-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=NC=C(C(=O)O)C=C1 KDHDWEZUYPKULD-UHFFFAOYSA-N 0.000 claims 2
- JUQHQWKGLUOANY-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoxaline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C=1C=C2N=CC(=NC2=CC=1)C(=O)O JUQHQWKGLUOANY-UHFFFAOYSA-N 0.000 claims 2
- MHXAQQOOOMIKDQ-UHFFFAOYSA-N 6-[3'-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]spiro[8-azabicyclo[3.2.1]octane-3,1'-cyclobutane]-8-yl]pyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1CC2(C1)CC1CCC(C2)N1C1=NC=C(C(=O)O)C=C1 MHXAQQOOOMIKDQ-UHFFFAOYSA-N 0.000 claims 2
- NZXJXRSUHMWMID-UHFFFAOYSA-N 6-[6-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-2-azaspiro[3.3]hept-6-en-2-yl]pyridine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(CN(C2)C2=NC=C(C(=O)O)C=C2)C1 NZXJXRSUHMWMID-UHFFFAOYSA-N 0.000 claims 2
- TWTJIUIXSVEUST-UHFFFAOYSA-N 7-[2-[3-(2,6-dichlorophenyl)-5-propan-2-yl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)Cl)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O)C(C)C TWTJIUIXSVEUST-UHFFFAOYSA-N 0.000 claims 2
- ZVTMIKFBLKEFJX-UHFFFAOYSA-N 7-[2-[3-(2-chloro-6-fluorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)F)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O)C1CC1 ZVTMIKFBLKEFJX-UHFFFAOYSA-N 0.000 claims 2
- FBPFLCYWDQZAGA-UHFFFAOYSA-N 7-[2-[3-(2-chloro-6-fluorophenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]isoquinoline-3-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)F)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=CC2=C1)C(=O)O)C1CC1 FBPFLCYWDQZAGA-UHFFFAOYSA-N 0.000 claims 2
- VCEZXCNWDVZXKF-UHFFFAOYSA-N 7-[2-[3-(2-chloro-6-methylphenyl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound ClC1=C(C(=CC=C1)C)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O)C1CC1 VCEZXCNWDVZXKF-UHFFFAOYSA-N 0.000 claims 2
- HDXNBOUIEPOPSM-UHFFFAOYSA-N 7-[2-[3-(3-chloropyridin-2-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]isoquinoline-3-carboxylic acid Chemical compound ClC=1C(=NC=CC=1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=CC2=C1)C(=O)O)C1CC1 HDXNBOUIEPOPSM-UHFFFAOYSA-N 0.000 claims 2
- HGDYOMFUBJYZMP-UHFFFAOYSA-N 7-[2-[3-(3-chloropyridin-4-yl)-5-cyclopropyl-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound ClC=1C=NC=CC=1C1=NOC(=C1C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O)C1CC1 HGDYOMFUBJYZMP-UHFFFAOYSA-N 0.000 claims 2
- JRLDPVKQZIVJHC-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-8-methylquinoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(C=NC2=C1C)C(=O)O JRLDPVKQZIVJHC-UHFFFAOYSA-N 0.000 claims 2
- SRSJZDUTBADUGN-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-(2,6-difluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O SRSJZDUTBADUGN-UHFFFAOYSA-N 0.000 claims 2
- PSVAAPLAQYYMRC-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-(2,6-difluorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]isoquinoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=CC2=C1)C(=O)O PSVAAPLAQYYMRC-UHFFFAOYSA-N 0.000 claims 2
- FUYZFDXKGPBRAB-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=NC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O FUYZFDXKGPBRAB-UHFFFAOYSA-N 0.000 claims 2
- JQSYSNUNDVELBP-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-8-methylquinoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(C=NC2=C1C)C(=O)O JQSYSNUNDVELBP-UHFFFAOYSA-N 0.000 claims 2
- WRQUNBYRAIBXPK-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O WRQUNBYRAIBXPK-UHFFFAOYSA-N 0.000 claims 2
- IYOJOLBRPNAFJA-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-[2-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]isoquinoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1)C(F)(F)F)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=CC2=C1)C(=O)O IYOJOLBRPNAFJA-UHFFFAOYSA-N 0.000 claims 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 2
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 2
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 2
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- ZSNGMDJGTIYZCO-UHFFFAOYSA-N N-cyclopropyl-2-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-fluoro-1,3-benzothiazole-6-carboxamide Chemical compound C1(CC1)NC(=O)C1=CC2=C(N=C(S2)N2CCC3(CC(=C3)C=3C(=NOC=3C3CC3)C3=C(C=NC=C3Cl)Cl)CC2)C(=C1)F ZSNGMDJGTIYZCO-UHFFFAOYSA-N 0.000 claims 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- BLFJCJKTSCOLEY-UHFFFAOYSA-N cinnoline-3-carboxylic acid Chemical compound C1=CC=C2N=NC(C(=O)O)=CC2=C1 BLFJCJKTSCOLEY-UHFFFAOYSA-N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- IIVUJUOJERNGQX-UHFFFAOYSA-N pyrimidine-5-carboxylic acid Chemical compound OC(=O)C1=CN=CN=C1 IIVUJUOJERNGQX-UHFFFAOYSA-N 0.000 claims 2
- ZEXKKIXCRDTKBF-UHFFFAOYSA-N quinoline-2-carboxamide Chemical compound C1=CC=CC2=NC(C(=O)N)=CC=C21 ZEXKKIXCRDTKBF-UHFFFAOYSA-N 0.000 claims 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 1
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 claims 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- BGAPLXQQSROBRZ-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC2=CC=C(C=C2C=C1)C(=O)O BGAPLXQQSROBRZ-UHFFFAOYSA-N 0.000 claims 1
- PKZVONDTIGQAGS-UHFFFAOYSA-N 2-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoxaline-6-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=NC2=CC=C(C=C2N=C1)C(=O)O PKZVONDTIGQAGS-UHFFFAOYSA-N 0.000 claims 1
- QLTYREDSJFUKOW-UHFFFAOYSA-N 5-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyrazine-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1N=CC(=NC=1)C(=O)O QLTYREDSJFUKOW-UHFFFAOYSA-N 0.000 claims 1
- CNOVSDYVNGGDOR-UHFFFAOYSA-N 5-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyrimidine-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=NC(=NC=1)C(=O)O CNOVSDYVNGGDOR-UHFFFAOYSA-N 0.000 claims 1
- AUKHRVOPBVAYTH-UHFFFAOYSA-N 6-[2-(3-cyclohexyl-5-cyclopropyl-1,2-oxazol-4-yl)-7-azaspiro[3.5]non-2-en-7-yl]-4-ethoxyquinoline-2-carboxylic acid Chemical compound C1(CCCCC1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OCC)C1CC1 AUKHRVOPBVAYTH-UHFFFAOYSA-N 0.000 claims 1
- ODCDUDICXHWLRS-UHFFFAOYSA-N 6-[2-(3-cyclohexyl-5-cyclopropyl-1,2-oxazol-4-yl)-7-azaspiro[3.5]non-2-en-7-yl]-4-methoxyquinoline-2-carboxylic acid Chemical compound C1(CCCCC1)C1=NOC(=C1C1=CC2(C1)CCN(CC2)C=1C=C2C(=CC(=NC2=CC=1)C(=O)O)OC)C1CC1 ODCDUDICXHWLRS-UHFFFAOYSA-N 0.000 claims 1
- SZECPXXSQKYPKM-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]pyridazine-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C(N=N1)C(=O)O SZECPXXSQKYPKM-UHFFFAOYSA-N 0.000 claims 1
- UXZHKRXZCXSKGC-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]quinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C=1C=C2C=CC(=NC2=CC=1)C(=O)O UXZHKRXZCXSKGC-UHFFFAOYSA-N 0.000 claims 1
- RROZJZRXMBPCTL-UHFFFAOYSA-N 6-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]spiro[3.5]non-2-en-7-yl]oxyquinoline-2-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCC(CC2)OC=1C=C2C=CC(=NC2=CC=1)C(=O)O RROZJZRXMBPCTL-UHFFFAOYSA-N 0.000 claims 1
- KTRGJFHLXZMCBX-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]cinnoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=NC2=C1)C(=O)O KTRGJFHLXZMCBX-UHFFFAOYSA-N 0.000 claims 1
- YQBJIOUMWBWRCM-UHFFFAOYSA-N 7-[2-[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]isoquinoline-3-carboxylic acid Chemical compound C1(CC1)C1=C(C(=NO1)C1=C(C=CC=C1Cl)Cl)C1=CC2(C1)CCN(CC2)C1=CC=C2C=C(N=CC2=C1)C(=O)O YQBJIOUMWBWRCM-UHFFFAOYSA-N 0.000 claims 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- 125000001691 aryl alkyl amino group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000005873 benzo[d]thiazolyl group Chemical group 0.000 claims 1
- LPCWKMYWISGVSK-UHFFFAOYSA-N bicyclo[3.2.1]octane Chemical compound C1C2CCC1CCC2 LPCWKMYWISGVSK-UHFFFAOYSA-N 0.000 claims 1
- 210000000013 bile duct Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000005884 carbocyclylalkyl group Chemical group 0.000 claims 1
- 230000001587 cholestatic effect Effects 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000003147 glycosyl group Chemical group 0.000 claims 1
- 125000004992 haloalkylamino group Chemical group 0.000 claims 1
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 208000010157 sclerosing cholangitis Diseases 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762580068P | 2017-11-01 | 2017-11-01 | |
| US62/580,068 | 2017-11-01 | ||
| PCT/US2018/058326 WO2019089672A1 (en) | 2017-11-01 | 2018-10-31 | Spirocyclic compounds as farnesoid x receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021501806A JP2021501806A (ja) | 2021-01-21 |
| JP2021501806A5 true JP2021501806A5 (enExample) | 2021-10-28 |
| JP7228595B2 JP7228595B2 (ja) | 2023-02-24 |
Family
ID=64332185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544335A Active JP7228595B2 (ja) | 2017-11-01 | 2018-10-31 | ファルネソイドｘ受容体モジュレーターとしてのスピロ環化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11078198B2 (enExample) |
| EP (1) | EP3704114B1 (enExample) |
| JP (1) | JP7228595B2 (enExample) |
| KR (1) | KR102731924B1 (enExample) |
| CN (1) | CN111278821B (enExample) |
| AR (1) | AR113819A1 (enExample) |
| AU (1) | AU2018357878A1 (enExample) |
| BR (1) | BR112020008157A2 (enExample) |
| CA (1) | CA3081424A1 (enExample) |
| CL (1) | CL2020001140A1 (enExample) |
| CO (1) | CO2020005486A2 (enExample) |
| EA (1) | EA202091101A1 (enExample) |
| ES (1) | ES2933184T3 (enExample) |
| IL (1) | IL274322A (enExample) |
| MX (1) | MX2020004400A (enExample) |
| PE (1) | PE20201184A1 (enExample) |
| SG (1) | SG11202003825TA (enExample) |
| TW (1) | TW201922737A (enExample) |
| WO (1) | WO2019089672A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023505116A (ja) * | 2019-11-29 | 2023-02-08 | ▲広▼▲東▼▲東▼▲陽▼光▲薬▼▲業▼有限公司 | 三環式含窒素化合物の結晶形及びその用途 |
| US20230002400A1 (en) * | 2019-11-29 | 2023-01-05 | Sunshine Lake Pharma Co., Ltd. | Amorphous form of nitrogen-containing tricyclic compound and use thereof |
| US20230060715A1 (en) | 2020-01-15 | 2023-03-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of fxr agonists for treating an infection by hepatitis d virus |
| CN111592557A (zh) * | 2020-05-09 | 2020-08-28 | 河北合佳医药科技集团股份有限公司 | 一种7-氨基-3-乙烯基头孢烷酸的一步法环保制备方法 |
| US20240100125A1 (en) | 2021-01-14 | 2024-03-28 | Enyo Pharma | Synergistic effect of a fxr agonist and ifn for the treatment of hbv infection |
| JP2024517181A (ja) | 2021-04-28 | 2024-04-19 | ウエヌイグレックオ・ファーマ | 組合せ治療としてｆｘｒアゴニストを使用するｔｌｒ３アゴニストの効果の強い増強 |
| KR102682408B1 (ko) * | 2021-05-12 | 2024-07-05 | 에이치케이이노엔 주식회사 | 신규한 벤조티아졸 유도체, 이의 제조방법 및 이의 간질환 예방 또는 치료 용도 |
| KR20260032385A (ko) * | 2024-08-28 | 2026-03-09 | 주식회사유한양행 | Glp-1 수용체 효능제 활성을 가진 시에노이미다졸 화합물, 이의 제조 방법, 및 이들의 의약 용도 |
| KR20260032384A (ko) * | 2024-08-28 | 2026-03-09 | 주식회사유한양행 | Glp-1 수용체 효능제 활성을 가진 벤즈이미다졸 화합물, 이의 제조 방법, 및 이들의 의약 용도 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993013101A1 (fr) | 1991-12-27 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose de pyridonecarboxylate, son utilisation pharmaceutique et compose spiro |
| AU4999897A (en) | 1996-10-25 | 1998-05-15 | Merck & Co., Inc. | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists |
| WO2006006490A1 (ja) | 2004-07-08 | 2006-01-19 | Ono Pharmaceutical Co., Ltd. | スピロ化合物 |
| CN101248048B (zh) * | 2005-06-27 | 2013-08-28 | 埃克塞利希斯专利有限责任公司 | 吡唑基lxr调节剂 |
| ES2374165T3 (es) | 2005-12-19 | 2012-02-14 | Glaxosmithkline Llc | Agonistas del receptor x farnesoide. |
| CN101679297B (zh) * | 2006-12-08 | 2012-01-11 | 埃克塞利希斯股份有限公司 | Lxr和fxr调节剂 |
| US20100035918A1 (en) | 2007-01-30 | 2010-02-11 | Biogen Idec Ma Inc | Imidazolone Compounds and Methods of Making and Using the Same |
| CA2690406A1 (en) | 2007-07-02 | 2009-01-08 | Glaxosmithkline Llc | Farnesoid x receptor agonists |
| WO2009009059A1 (en) | 2007-07-09 | 2009-01-15 | Biogen Idec Ma Inc. | Spiro compounds as antagonists of tgf-beta |
| TW200906823A (en) | 2007-07-16 | 2009-02-16 | Lilly Co Eli | Compounds and methods for modulating FXR |
| KR20100075643A (ko) | 2007-10-22 | 2010-07-02 | 쉐링 코포레이션 | 비사이클릭 헤테로사이클 유도체 및 ｇｐｒ119의 활성의 조절인자로서의 이의 용도 |
| CA2741839A1 (en) | 2008-11-21 | 2010-05-27 | Pfizer Inc. | 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors |
| US8440710B2 (en) | 2009-10-15 | 2013-05-14 | Hoffmann-La Roche Inc. | HSL inhibitors useful in the treatment of diabetes |
| CU24152B1 (es) * | 2010-12-20 | 2016-02-29 | Irm Llc | 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr |
| JO3154B1 (ar) * | 2011-06-17 | 2017-09-20 | Glaxosmithkline Llc | عوامل مضادة لـ trpv4 |
| EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
| US9403839B2 (en) * | 2012-01-16 | 2016-08-02 | Vertex Pharmaceuticals Incorporated | Pyran-spirocyclic piperidine amides as modulators of ion channels |
| HRP20161774T1 (hr) | 2012-06-13 | 2017-02-24 | F. Hoffmann - La Roche Ag | Novi diazaspirocikloalkan i azaspirocikloalkan |
| JP6099753B2 (ja) | 2012-10-03 | 2017-03-22 | アドビナス セラピューティクス リミテッド | スピロ環化合物、その組成物及びその医薬応用 |
| US9403810B2 (en) * | 2014-05-14 | 2016-08-02 | Novartis Ag | Carboxamide derivatives |
| WO2015172747A1 (en) | 2014-05-16 | 2015-11-19 | Zhaoyin Wang | Spirocyclic molecules as mth1 inhibitors |
| EP3034499A1 (en) | 2014-12-17 | 2016-06-22 | Gilead Sciences, Inc. | Novel FXR (NR1H4) modulating compounds |
| EP3034501A1 (en) | 2014-12-17 | 2016-06-22 | Gilead Sciences, Inc. | Hydroxy containing FXR (NR1H4) modulating compounds |
| BR112017011972A2 (pt) | 2014-12-18 | 2017-12-26 | Novartis Ag | derivados de azabicicloctano como agonistas de fxr para uso no tratamento de doenças hepáticas e gastrintestinais |
| CN106146483A (zh) | 2015-04-23 | 2016-11-23 | 上海迪诺医药科技有限公司 | 杂环类法尼酯衍生物x受体调节剂 |
| CN106946867B (zh) * | 2016-01-06 | 2019-11-12 | 广州市恒诺康医药科技有限公司 | Fxr受体调节剂及其制备方法和用途 |
| WO2017133521A1 (zh) | 2016-02-01 | 2017-08-10 | 山东轩竹医药科技有限公司 | Fxr受体激动剂 |
| CN107021958A (zh) | 2016-02-01 | 2017-08-08 | 山东轩竹医药科技有限公司 | Fxr受体激动剂 |
| DK3419625T3 (da) | 2016-02-22 | 2021-07-12 | Novartis Ag | Fremgangsmåder til anvendelse af fxr-agonister |
| JP6941109B2 (ja) | 2016-02-22 | 2021-09-29 | ノバルティス アーゲー | Ｆｘｒアゴニストを使用するための方法 |
| WO2017189652A1 (en) | 2016-04-26 | 2017-11-02 | Enanta Pharmaceuticals, Inc. | Isoxazole derivatives as fxr agonists and methods of use thereof |
| WO2017189663A1 (en) | 2016-04-26 | 2017-11-02 | Enanta Pharmaceuticals, Inc. | Isoxazole derivatives as fxr agonists and methods of use thereof |
| US10080742B2 (en) | 2016-04-26 | 2018-09-25 | Enanta Pharmaceuticals, Inc. | Isoxazole derivatives as FXR agonists and methods of use thereof |
| US10149835B2 (en) | 2016-05-18 | 2018-12-11 | Elmore Patent Law Group, P.C. | Isoxazole derivatives as FXR agonists and methods of use thereof |
| AR108711A1 (es) | 2016-06-13 | 2018-09-19 | Gilead Sciences Inc | Compuestos moduladores de fxr (nr1h4) |
| ES2921432T3 (es) | 2016-06-13 | 2022-08-25 | Gilead Sciences Inc | Derivados de azetidina como moduladores de FXR (NR1H4) |
| WO2018059314A1 (zh) | 2016-09-28 | 2018-04-05 | 四川科伦博泰生物医药股份有限公司 | 氮杂双环衍生物及其制备方法和用途 |
| CN106632294A (zh) | 2016-12-15 | 2017-05-10 | 宁波百纳西药业有限公司 | 一种螺环化合物及其药物用途 |
-
2018
- 2018-10-31 KR KR1020207015273A patent/KR102731924B1/ko active Active
- 2018-10-31 JP JP2020544335A patent/JP7228595B2/ja active Active
- 2018-10-31 AR ARP180103176A patent/AR113819A1/es unknown
- 2018-10-31 AU AU2018357878A patent/AU2018357878A1/en not_active Abandoned
- 2018-10-31 EA EA202091101A patent/EA202091101A1/ru unknown
- 2018-10-31 US US16/175,910 patent/US11078198B2/en active Active
- 2018-10-31 BR BR112020008157-4A patent/BR112020008157A2/pt not_active IP Right Cessation
- 2018-10-31 WO PCT/US2018/058326 patent/WO2019089672A1/en not_active Ceased
- 2018-10-31 EP EP18804190.9A patent/EP3704114B1/en active Active
- 2018-10-31 ES ES18804190T patent/ES2933184T3/es active Active
- 2018-10-31 CN CN201880069863.0A patent/CN111278821B/zh active Active
- 2018-10-31 MX MX2020004400A patent/MX2020004400A/es unknown
- 2018-10-31 PE PE2020000676A patent/PE20201184A1/es unknown
- 2018-10-31 CA CA3081424A patent/CA3081424A1/en not_active Abandoned
- 2018-10-31 TW TW107138488A patent/TW201922737A/zh unknown
- 2018-10-31 SG SG11202003825TA patent/SG11202003825TA/en unknown
-
2020
- 2020-04-28 IL IL274322A patent/IL274322A/en unknown
- 2020-04-29 CL CL2020001140A patent/CL2020001140A1/es unknown
- 2020-04-30 CO CONC2020/0005486A patent/CO2020005486A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021501806A5 (enExample) | ||
| US12331056B2 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
| EP3630770B1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| AU2018374456B2 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| AU2010249380B2 (en) | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as Janus kinase inhibitors | |
| CN114728935A (zh) | Shp2抑制剂 | |
| JP2020514267A5 (enExample) | ||
| US20240059703A1 (en) | Heterocyclic spiro compounds and methods of use | |
| US8742098B2 (en) | Inhibitors of Bruton's tyrosine kinase | |
| RU2015129538A (ru) | Замещенные имидазопиридины в качестве ингибиторов hdm2 | |
| JP2014528482A5 (enExample) | ||
| EP4288431A1 (en) | Azabicyclic shp2 inhibitors | |
| KR20180095595A (ko) | 키나제 억제제로서의 트리시클릭 화합물 및 조성물 | |
| CN116171280A (zh) | 酪蛋白激酶1δ调节剂 | |
| JPWO2019089670A5 (enExample) | ||
| JPWO2019156987A5 (enExample) | ||
| JPWO2019089664A5 (enExample) | ||
| RU2846525C2 (ru) | Ингибиторы shp2 фосфатазы и способы их применения | |
| HK1168823A (en) | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |